Mitchell A.H. Levine BSc (McGill), MD (Calgary), MSc (McMaster), FRCPC, FISPE

Professor, Department of Clinical Epidemiology & Biostatistics
Joint Member, Department of Medicine

Director, Centre for Evaluation of Medicines
Active Staff, St. Joseph's Hospital

Editor-in-Chief, Canadian Journal of Clinical Pharmacology
Associate Editor, ACP Journal Club
Associate Editor, Evidence Based Medicine
Pharmacoeconomic consultant, Drug Quality and Therapeutics Committee (DQTC), MOHLTC
Member, Advisory Committee on Management for the Therapeutics Product Directorate at Health Canada
Member, Patented Medicine Prices Review Board's Human Drug Advisory Panel

Tel: 905-522-1155   x 34276
Fax: 905-528-7386
E-mail: levinem@mcmaster.ca

Postal address:
Centre for Evaluation of Medicines
St. Joseph's Healthcare Hamilton
105 Main St. E., P1
Hamilton, ON L8N 1G6

Administrative Assistant:

Ann Costie
Tel: 905-522-1155   x34276
Fax: 905-528-738
E-mail: costiea@mcmaster.ca

Dr. Levine's principal research interests are in assessing prescription drug use in the community and developing methods for promoting cost-effective use of drug therapy.  One key project is the Prescription Medication Monitoring Programme.  It is a research programme that collects data on how drugs are actually used in the community and the impact they have on health care resource use and on patient quality of life.  Another project is the dissemination of evidence-based prescribing information for primary care physicians through the "Drugs of Choice" formulary.  A major focus of research involves the study of how physician and patient values influence the use of drug therapies. 

Current HRM Graduate Students:

Hani Abushomar, PhD student
Joanne Duncan, MSc student

Recent HRM Graduate Students:

Pendar Farahani, MSc 2005
Jane Jurcic, MSc 2005

1. Farahani P, Levine M, Gaebel K, LeLorier J, Perreault S, Gillis J, Soon J.  Exploring patient demographic and clinical characteristics associated with lipid-lowering pharmacotherapy use in primary care.  Clin Invest Med 2007;30(2)E63-E69.
2. Singh SR, Levine MAH.  Potential Interactions between Pharmaceuticals and Natural Health Products in Canada:   J Clin Pharmacol 2007;47:1-10
3. Farahani, P, Levine M, Gaebel K, Thabane L.  Clinical Data Gap Between Phase III Clinical Trials (Pre-Marketing) And Phase IV (Post-Marketing) Studies: Evaluation of Etanercept In Rheumatoid Arthritis. Can J Clin Pharmacol 2005;12(3): e254-e263.
4. Levine MAH, Gaebel K. A study of patient responses to a perceived change in salbutamol metered dose inhalers. J Generic Med 2005;2(3):201-208.
5. McCormack JP, Dolovich L, Levine M et al. Providing evidence-based information to patients in general practice and pharmacies: What is the acceptability, usefulness and impact on drug use? Health Expectations 2003;6:281-9.
6. Brazier N, Levine MAH. Drug Herb Interaction Among Commonly Used Conventional Medicines: A Compendium for Health Care Professionals. Am J Ther 2003;10(3):163-9.
7. Heyland DK, Gafni A, Levine MAH. Do potential patients prefer tPA or SK? J Clin Epid 2000;53: 888-894.
8. Levine MAH, Lexchin J, Pelizzarri R. Drugs of choice formulary, 3rd Edition. CMA Publishing, Ottawa, 1999.
9. Levine MAH, Hamet P, Novosel S, Jolain B. A prospective comparison of four study designs used in assessing safety and effectiveness of drug therapy in hypertension management. Amer J Hypertension 1997;10:1-10.

Search for citations for Dr. Levine on PubMed

To update this page please contact - hcarr@mcmaster.ca